Monday, September 2, 2013

Methods for treatment of brain injury utilizing biologics

Ok, the stupidity of patenting drug delivery is here for all to see. This is the guy that is trying to push Enbrel/etanercept as a stroke treatment.  He now has included nasal delivery and delivery thru the skin in the patent. This patent needs to be invalidated. The only drug delivery he doesn't try to patent is intravenous and oral.  A great stroke association would object to this.
Stupid, stupid, stupid. 
http://www.freepatentsonline.com/y2013/0224197.html
A method of using biologics to treat chronic brain injury or spasticity due to stroke, trauma and other causes. Preferred embodiments include perispinal, parenteral, transepidermal or intranasal use of TNF antagonists. The TNF antagonists include TNF receptor fusion proteins, TNF monoclonal antibodies (mAbs), humanized TNF mAbs, fully human TNF mAbs, chimeric TNF mAbs, domain TNF antibodies, mAB fragments, anti-TNF nanobodies, dominant negative TNF constructs and TNF inhibitory single chain antibody fragments. One of the preferred embodiments of this invention is the perispinal administration of etanercept for treatment of mammals following stroke. The use of Trendelenburg positioning, catheters, pumps, or depot formulations are included.

No comments:

Post a Comment